Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Chongqing University Cancer Hospital · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
nanasopharyngeal-carcinoma
nasopharyngeal cancinoma (npc), nasopharyngeal carcinoma, de novo metastatic, tislelizumab, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 888583
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.